Financial reports
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-K/A
2022 FY
Annual report (amended)
23 Oct 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
31 Mar 22
Current reports
8-K
HeartCore Signs 13th Go IPO Contract
18 Mar 24
8-K
HeartCore Signs 12th Go IPO Contract
29 Feb 24
8-K
HeartCore Reports Third Quarter 2023 Financial Results
13 Nov 23
8-K
Departure of Directors or Certain Officers
7 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
30 Oct 23
8-K
Entry into a Material Definitive Agreement
23 Oct 23
8-K
Termination of a Material Definitive Agreement
12 Oct 23
8-K
HeartCore’s CMS Platform Awarded Top Market Share in Japan for Eight Consecutive Years
10 Oct 23
8-K
Entry into a Material Definitive Agreement
5 Oct 23
8-K
HeartCore Signs Eleventh Go IPO Contract
3 Oct 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
23 Oct 23
424B3
Prospectus supplement
23 Oct 23
424B5
Prospectus supplement for primary offering
31 May 23
S-3/A
Shelf registration (amended)
7 Apr 23
S-8
Registration of securities for employees
14 Mar 23
S-3
Shelf registration
13 Mar 23
424B4
Prospectus supplement with pricing info
10 Feb 22
D
$1M in equity, sold $760K, 15 investors
9 Feb 22
8-A12B
Registration of securities on exchange
8 Feb 22
S-1/A
IPO registration (amended)
8 Feb 22
Proxies
Other
EFFECT
Notice of effectiveness
13 Apr 23
CORRESP
Correspondence with SEC
11 Apr 23
EFFECT
Notice of effectiveness
10 Feb 22
CERT
Certification of approval for exchange listing
8 Feb 22
CORRESP
Correspondence with SEC
8 Feb 22
CORRESP
Correspondence with SEC
8 Feb 22
CORRESP
Correspondence with SEC
8 Feb 22
UPLOAD
Letter from SEC
7 Feb 22
CORRESP
Correspondence with SEC
25 Jan 22
UPLOAD
Letter from SEC
20 Jan 22